Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Implementation of the reinforced care pathways framework in France

On November 17, 2024, the Ministry of Health and Access to Care published an Order in the Official Journal of the French Republic on the support and reimbursement of reinforced care pathways. The new framework, introduced by Decree No. 2024-1035, aims to enhance the coordination and quality of care for patients with complex health needs.

Per the new framework, the healthcare professionals involved in a patient's care can develop and submit the coordinated care project to the regional health agency (ARS) and the primary health insurance fund (CPAM) via a dedicated online procedure. Only projects that meet the criteria set by the public health code and are not opposed by the ARS are eligible for reimbursement.

The reimbursement amount will be determined based on the nature and number of interventions required, including necessary equipment costs.

The framework for reinforced care pathways is a direct outcome of the experimental projects under Article 51 of the Social Security Financing Act of 2018, which aimed to innovate healthcare delivery and financing models.

See the full details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.